Stock Track | METIS TECHBIO-P Plummets 12.26% Intraday Amid Post-IPO Correction and Profit-Taking Pressure

Stock Track05-26

METIS TECHBIO-P's stock plummeted 12.26% during intraday trading, continuing a downward trend that began after its highly anticipated initial public offering.

The AI drug delivery company, which saw its shares surge 173% on its debut, is facing sustained selling pressure as early-stage commercialization challenges become apparent. The company has accumulated approximately RMB 1.5 billion in losses over the past three years with volatile revenue streams.

Adding to the downward pressure, certain internationally placed shares carry no lock-up restrictions, allowing early investors to exit positions and take profits. The fading enthusiasm that typically follows new listings has accelerated this correction phase as the market reassesses the company's fundamentals.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment